<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02333279</url>
  </required_header>
  <id_info>
    <org_study_id>FUP062</org_study_id>
    <secondary_id>snctp000000587</secondary_id>
    <nct_id>NCT02333279</nct_id>
  </id_info>
  <brief_title>Cancer Development In Organ Transplant Recipients</brief_title>
  <official_title>Cancer Development In Organ Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will determine the cancer risk in organ transplant recipients compared to
      the general population with the help of statistical analysis. Secondly the investigators will
      try to characterize the different cancer types.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This cohort analyses will focus on incident and recurrent cases of development of non-skin
      cancer over time. We will consider time to first formation of non-skin solid cancer after
      solid organ transplantation as well as the cumulative number of non-skin solid cancer
      formation over time. Both aspects are equally important and will be reflected in the analytic
      methods of this study. Theses analyses will be restricted to the most prevalent
      transplantation types of heart, kidney, liver, and lung.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2008</start_date>
  <completion_date type="Actual">July 2019</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Number of solid cancers</measure>
    <time_frame>Ten Year followup</time_frame>
    <description>Number of solid cancers</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1800</enrollment>
  <condition>Heart Cancer</condition>
  <condition>Kidney Cancer</condition>
  <condition>Lung Cancer</condition>
  <condition>Pancreas Cancer</condition>
  <condition>Liver Cancer</condition>
  <arm_group>
    <arm_group_label>Organ transplant recipients</arm_group_label>
    <description>Follow-ups in regular intervals following the organ transplant date.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All solid organ transplant recipients in Switzerland since 2008 who have given their
        consent to be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        We will select all patients within the STCS based on the date of the first solid organ
        transplantation. Patients with multiple organ transplantations will be included as well.
        Patients contribute to the study observation time until death or end of follow-up due to
        other reasons.

        Exclusion Criteria:

        We will exclude patients with non-solid organ transplantation (e.g. hematopoietic stem cell
        transplantation), because the detailing of information in the STCS is insufficient to allow
        for detailed analysis of cancer development and control of relevant confounders. We will
        exclude
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunther FL Hofbauer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Zürich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Dermatology</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Lengwiler E, Stampf S, Zippelius A, Salati E, Zaman K, Schäfer N, Schardt J, Siano M, Hofbauer G, The Swiss Transplant Cohort Study. Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study. Swiss Med Wkly. 2019 May 19;149:w20078. doi: 10.4414/smw.2019.20078. eCollection 2019 May 6.</citation>
    <PMID>31104307</PMID>
  </results_reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>December 18, 2014</study_first_submitted>
  <study_first_submitted_qc>January 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2015</study_first_posted>
  <last_update_submitted>July 25, 2019</last_update_submitted>
  <last_update_submitted_qc>July 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

